Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Outcomes for patients ...

Multiple myeloma is the second most commonly diagnosed type of blood cancer (after lymphoma). But it’s still relatively uncommon. Around the world, there were about 180,000 new cases in 2022. That ...

If you or a loved one has just learned they have multiple myeloma, the diagnosis may come as a surprise. Chances are that you don’t know much -- if anything -- about this type of cancer, so you’ll ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is ...

In a 2024 review, Richardson and colleagues noted that the immunomodulatory drugs thalidomide, lenalidomide (Revlimid), and ...

Smoldering multiple myeloma (SMM) is a condition that affects plasma cells in the bone marrow. These are a type of white blood cell that help keep the body safe from infection. SMM is a subdivision of ...

Multiple myeloma (MM) is caused by the clonal expansion of plasma cells in the bone marrow. While survival from MM has improved significantly over the last decade with the introduction of ...

Multiple myeloma causes an overgrowth of cancerous plasma cells in your bone marrow. When these cancerous cells crowd out the healthy cells in your bone marrow, thrombocytopenia can occur. Multiple ...

Smoldering multiple myeloma (SMM) is a precancerous condition affecting white blood cells, called plasma cells, in the bone marrow. It can turn into multiple myeloma, a form of blood cancer that can ...